Measurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagents. [electronic resource]
Producer: 20140421Description: e71703 p. digitalISSN:- 1932-6203
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Aptamers, Nucleotide -- genetics
- Binding Sites
- Binding, Competitive
- Biomarkers -- blood
- Cetuximab
- Clinical Laboratory Techniques -- methods
- Enzyme-Linked Immunosorbent Assay
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Panitumumab
- Polymerase Chain Reaction
- Receptor, ErbB-2 -- antagonists & inhibitors
- Receptor, ErbB-3 -- antagonists & inhibitors
- Receptor, ErbB-4
- Reproducibility of Results
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.